Successful treatment of severe acrodermatitis continua of Hallopeau with guselkumab
DOI:
https://doi.org/10.5070/dhcdfs98Keywords:
acrodermatitis continua, Hallopeau, palmoplantar pustulosis, psoriasisDownloads
References
1. Navarini AA, Burden AD, Capon F, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31:1792-1799. [PMID: 28585342].
2. Weisenseel P, Wilsmann-Theis D, Kahl C, Reich K, Mössner R. [Pustular psoriasis]. Hautarzt Z Dermatol Venerol Verwandte Geb. 2016;67:445-453. [PMID: 27240667].
3. Bachelez H. Pustular psoriasis and related pustular skin diseases. Br J Dermatol. 2018;178:614-618. [PMID: 29333670].
4. Shah M, Al Aboud DM, Crane JS, Kumar S. Pustular Psoriasis. In: StatPearls. StatPearls Publishing; 2024. [PMID: 30725687].
5. Kromer C, Loewe E, Schaarschmidt ML, et al. Treatment of acrodermatitis continua of Hallopeau: A case series of 39 patients. J Dermatol. 2020;47:989-997. [PMID: 32632983].
6. Buononato D, Licata G, Gambardella A, De Rosa A, Calabrese G, Argenziano G. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab. Dermatol Ther. 2022;35:e15514. [PMID: 35420733].
7. Yamamoto H, Kamiya K, Okada H, Maekawa T, Komine M, Ohtsuki M. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab. Int J Dermatol. 2023;62:269-270. [PMID: 35187654].
8. Langer N, Wilsmann-Theis D, Kromer C, Mohr J, Mössner R. Successful therapy of acrodermatitis continua of Hallopeau with IL-23 blockers -two new cases. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2021;19:1504-1507. [PMID: 34581001].
9. Di Costanzo L, Napolitano M, Patruno C, Cantelli M, Balato N. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab. J Dermatol Treat. 2014;25:489-494. [PMID: 24215490].
10. Lefkir S, Slimani S, Brahimi N, Ladjouze-Rezig A. Successful treatment of Acrodermatitis continua of Hallopeau associated with psoriatic arthritis with adalimumab. Eur J Rheumatol. 2015;2:78-79. [PMID: 27708932].
11. Pilz AC, Roenneberg S, Biedermann T, Eyerich K. Ixekizumab for acrodermatitis continua. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2018;16:907-910. [PMID: 29927543].
12. Gargiulo L, Toso F, Ibba L, Valenti M, Costanzo A, Narcisi A. Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab. Dermatol Pract Concept. 2023;13:e2023103. [PMID: 37196286].
13. Schmid E, Mohr J, Schön MP, Mössner R. Two cases of acrodermatitis continua suppurativa (Hallopeau’s disease) treated with IL-17A inhibitors. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2019;17:643-645. [PMID: 31241836].
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Neda Cramer, Sara Isik, Michael P. Schön, Rotraut Mössner (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.